Pacira Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

21.10.24	Pacira BioSciences Appoints Shawn Cross As CFO (RTTNews)
25.09.24	DOMA Believes Pacira's Current Stock Price Represents Opportunity For Shareholder Return (RTTNews)
10.05.24	Pacira BioSciences Announces Pricing Of $250 Mln Of Convertible Senior Notes, Due 2029 (RTTNews)
13.03.24	Pacira BioSciences Receives RMAT Designation For Gene Therapy Product Candidate In Osteoarthritis (RTTNews)
21.12.23	Pacira BioSciences Appoints Frank Lee To Succeed David Stack As CEO (RTTNews)
10.11.23	Pacira Announces FDA Approval Of Expanded EXPAREL Label To Include Two Addl Nerve Block Indications (RTTNews)
28.10.23	Biotech Stocks Facing FDA Decision In November 2023 (RTTNews)
29.03.23	Pacira's SNDA For Extension Of Exparel Label Accepted By FDA (RTTNews)
17.11.22	New Research Reveals Common Treatments for Knee Pain are Falling Short, Placing Physical, Social, and Mental Burden on Patients (PR Newswire)
21.09.22	Pacira BioSciences Reports Positive Topline Data From Phase 3 Study Of EXPAREL (RTTNews)
07.09.22	Pacira BioSciences Announces Positive Data From Phase 3 Study Of EXPAREL In Postsurgical Pain (RTTNews)
14.07.22	Pacira BioSciences Reports $35 Mln Increase In Q2 Prel. Revenue (RTTNews)
16.06.22	National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Program Focused on Opioid Use and Misuse (PR Newswire)
25.05.22	Pacira BioSciences and the National Senior Games Association Break a GUINNESS WORLD RECORDS™ Title for the Largest Game of Freeze Dance (PR Newswire)
11.10.21	Pacira BioSciences To Buy Flexion Therapeutics - Quick Facts (RTTNews)
27.07.21	Biotech Stocks Facing FDA Decision In August 2021 (RTTNews)
23.03.21	AZN's COVID-19 Jab Shows 79% Efficacy, ZEAL Wins FDA Approval, AdComm To Review Osteoarthritis Drug (RTTNews)
30.06.20	FDA Snubs HRTX Again, ICPT Disappoints, KNSA Hits Right Notes, Is The Writing On The Wall For VRCA? (RTTNews)
02.05.19	Nabriva, Heron Bleed On FDA Rejection (RTTNews)
02.05.19	6 Top Gainers In Pharma Sector (ABIO, PRPO, VCYT...) (RTTNews)
05.03.19	Pacira Pharma To Acquire MyoScience Inc. - Quick Facts (RTTNews)
20.06.18	ANIK Plunges On Disappointing Data, MRNS Initiates Marigold, SSKN On Watch (RTTNews)
08.04.18	An Ear To The Pharma: 9 Stocks To Watch This Week (SELB, AGLE, BPMC, MNOV…) (RTTNews)
01.04.18	An Ear To The Pharma: 5 Stocks To Watch This Week (RTTNews)
28.03.18	Biotech Stocks Facing FDA Decision In April (RTTNews)
16.02.18	PCRX Slumps On FDA Panel Feedback, DOVA Hits Record High, AGIO Up 38% YTD (RTTNews)
26.01.18	Biotech Stocks Facing FDA Decision In February (RTTNews)
29.11.17	Cancer Treatment Centers of America® Teams with Pacira Pharmaceuticals, Inc. on Innovative Collaboration to Educate Physicians and Patients about Responsible Opioid Use (PR Newswire)
15.11.17	FDA Nod For AZN's Asthma Drug, Genmab Revises Outlook, NBY Disappoints (RTTNews)
09.11.17	DEPO Building New Specialty Business, FPRX Rebounds, HALO Glows (RTTNews)
11.08.17	Generic Drugs Stock Performance Review -- Pacira Pharma, Eagle Pharma, Neos Therapeutics, and Zynerba Pharma (PR Newswire)
26.07.17	Gainers & Losers Of July 25: FLKS, MYOK, SYRS, PCRX, RETA... (RTTNews)
12.06.17	Generic Drugs Stock Performance Review -- Ironwood Pharma, Medicines Co., Supernus Pharma, and Pacira Pharma (PR Newswire)
01.05.17	How These Generic Drugs Stocks are Faring? -- Medicines Co., Ironwood Pharma, Pacira Pharma, and Supernus Pharma (PR Newswire)
30.03.17	Pain-Reducing Combination Therapies Proving Successful Thanks to Innovative, Specialty Pharma Players (PR Newswire)
28.03.17	Research Reports Initiation on Generic Drugs Stocks -- Medicines, Ironwood Pharma, Pacira Pharma, and Supernus Pharma (PR Newswire)
16.02.17	How These Healthcare Stocks are Faring? -- GlaxoSmithKline, Shire, Pacira Pharma, and Supernus Pharma (PR Newswire)
25.01.17	DePuy Synthes Announces Exclusive Co-Promotional Agreement with Pacira Pharmaceuticals, Inc. (PR Newswire)
12.01.17	Research Reports Coverage on Healthcare Stocks -- Pacira Pharma, Supernus Pharma, Lipocine, and IntelliPharmaCeutics (PR Newswire)
22.11.16	Research Reports Initiation on Healthcare Stocks -- Perrigo, Pacira Pharma, Supernus Pharma, and PerkinElmer (PR Newswire)
19.04.16	Pacira Pharma Appoints Charles Reinhart, III As CFO - Quick Facts (RTTNews)
15.12.15	Pacira Reports Favorable Resolution With FDA On EXPAREL (RTTNews)
15.07.15	CELG Snaps Up RCPT, PETX Has Its Day, BIOC, RWLK Roll Out Products (RTTNews)
24.02.15	Pacira Pharma Swings To Profit In Q4 - Quick Facts (RTTNews)
08.01.15	Pacira Pharma Sees Q4, 2014 Revenues Above Estimates - Quick Facts (RTTNews)
13.10.14	Pacira Says Data Shows Safety Of EXPAREL Similar To Placebo And Bupivacaine HCl (RTTNews)
25.09.14	Pacira Pharma Receives FDA Warning Letter Regarding Exparel (RTTNews)
25.09.14	FDA Issues Warning Letter To Pacira Pharma Regarding EXPAREL (RTTNews)
05.08.14	Will PCRX Join The $100 Club? (RTTNews)
07.05.14	Pacira Pharma Submits SNDA In Nerve Block Indication For Exparel (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Logitech Intl	73.58	1.77 %	K V
ABB	51.70	0.86 %	K V
Sonova Hldg	299.90	0.74 %	K V
Part Grp Hldg	1’309.00	0.73 %	K V
CieFinRichemont	128.55	0.71 %	K V
Swiss Life Hldg	687.60	-0.41 %	K V
Zurich Insur Gr	558.00	-0.50 %	K V
Kuehne+Nagel Int	212.10	-0.61 %	K V
Givaudan	3’866.00	-1.07 %	K V
Novartis	91.25	-1.90 %	K V

Nachrichten zu Pacira Pharmaceuticals Inc.

Aktien Top/Flop

Meistgelesene Nachrichten